Medtronic PLC at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Well, good morning and good afternoon for those of you on the East Coast. My name is David Lewis, medical device analyst here at Morgan Stanley, and thanks for joining us here for the continuing coverage of day 1 of the Morgan Stanley Health Care Conference 2020.
It's my pleasure to have with us here as we progress through the day Medtronic and their Chief Executive Officer, Geoff Martha. This is the first time Geoff's been at our conference as CEO of Medtronic, and we've already seen a significant number of action changes under Geoff's tenure of the business. We're going to start off this morning. Geoff's going to give us a bit of preamble and talk about some of his early thoughts on the business, and then we're going to jump into Q&A.
With that, Geoff, the floor is yours.
All right. Thanks, David. So first of all, thanks for having me. It's great to be here. And you're right, there's been quite a bit of activity at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |